Even the most promising drug will fail if it never reaches its target. So before starting large clinical trials, pharmaceutical companies must determine, among other things, the precise dosage to use, a process that can be expensive and time-consuming. Scientists investigating a drug for Parkinson’s disease have now shown how an MRI scan can quickly determine the optimal dosage for drugs that act on the brain.
SOURCE
